ArticleJournal of digital imaging2018
Development and Validation of Segmentation Method for Lung Cancer Volumetry on Chest CT.
Article in Journal of digital imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 10 citations in OpenAlex.
- Binary Classification of Pneumonia in Chest X-Ray Images Using Modified Contrast-Limited Adaptive Histogram Equalization Algorithm.Sensors (Basel, Switzerland) · 2025Article
- Impact of CT-determined low kidney volume on renal function decline: a propensity score-matched analysis.Insights into imaging · 2024Article
- Relationship between Thyroid CT Density, Volume, and Future TSH Elevation: A 5-Year Follow-Up Study.Life (Basel, Switzerland) · 2023Article
- Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease.Journal of clinical medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The set of criteria called Response Evaluation Criteria In Solid Tumors (RECIST) is used to evaluate the remedial effects of lung cancer, whereby the size of a lesion can be measured in one dimension (diameter). Volumetric evaluation is desirable for estimating the size of a lesion accurately, but there are several constraints and limitations to calculating the volume in clinical trials. In this study, we developed a method to detect lesions automatically, with minimal intervention by the user, and calculate their volume. Our proposed method, called a spherical region-growing method (SPRG), uses segmentation that starts from a seed point set by the user. SPRG is a modification of an existing region-growing method that is based on a sphere instead of pixels. The SPRG method detects lesions while preventing leakage to neighboring tissues, because the sphere is grown, i.e., neighboring voxels are added, only when all the voxels meet the required conditions. In this study, two radiologists segmented lung tumors using a manual method and the proposed method, and the results of both methods were compared. The proposed method showed a high sensitivity of 81.68-84.81% and a high dice similarity coefficient (DSC) of 0.86-0.88 compared with the manual method. In addition, the SPRG intraclass correlation coefficient (ICC) was 0.998 (CI 0.997-0.999, p < 0.01), showing that the SPRG method is highly reliable. If our proposed method is used for segmentation and volumetric measurement of lesions, then objective and accurate results and shorter data analysis time are possible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.